RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
REVVITY, INC.
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Aug 11, 2026
$150.94−1.70 (-1.11%)
Close on Oct 19, 2026
- Market cap
- $16.85B
- P/E (TTM)
- 71.9
- Dividend yield
- 0.19%
REVVITY, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics [Member] | $1.47B | $1.45B | $1.42B | $1.39B | $1.38B | $1.37B | $1.36B | $1.21B | $1.23B | $1.26B | $1.29B | $1.48B | 50.4% | +6.4% |
| Life Sciences [Member] | $1.45B | $1.45B | $1.43B | $1.42B | $1.42B | $1.40B | $1.40B | $1.51B | $1.48B | $1.47B | $1.46B | $1.32B | 49.6% | +1.8% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $2.41B | $2.41B | $2.39B | $2.37B | $2.37B | $2.35B | $2.34B | $2.33B | $2.34B | $2.37B | $2.42B | $2.45B | 82.6% | +1.3% |
| Service [Member] | $506.72M | $490.02M | $466.07M | $446.47M | $424.80M | $417.82M | $416.82M | $391.15M | $371.16M | $353.17M | $334.68M | $342.61M | 17.4% | +19.3% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $1.27B | $1.27B | $1.26B | $1.25B | $1.25B | $1.23B | $1.22B | $1.21B | $1.20B | $1.21B | $1.22B | $1.25B | 43.6% | +1.6% |
| Europe [Member] | $891.64M | $866.23M | $824.98M | $785.25M | $764.89M | $745.84M | $742.61M | $737.64M | $733.66M | $740.69M | $747.02M | $752.66M | 30.6% | +16.6% |
| Asia [Member] | $750.84M | $768.85M | $775.11M | $774.01M | $784.42M | $790.66M | $789.33M | $778.29M | $777.69M | $777.00M | $787.94M | $789.57M | 25.8% | -4.3% |
From the segment and revenue-disaggregation notes of Revvity's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.